Sheldon Krimsky, Leader in Science Policy and Ethics, Dies at 80

Krimsky warned strenuously about the corrupting power of money in science.

Written byLisa Winter
| 2 min read
Man leaning against a bookshelf
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Ethical guidelines put in place to protect scientific integrity often struggle to keep pace with new technologies developed at breakneck speeds, especially as the nuances of policy are revealed and debated. For decades, one of the most vocal advocates for clear, consistent ethical frameworks in research was Sheldon Krimsky, who died unexpectedly on April 23 at the age of 80.

Krimsky was born in Brooklyn, New York, in 1942. According to The New York Times, his father painted houses while his mother worked as a seamstress. He remained close to home, attending Brooklyn College to earn bachelor’s degrees in physics and math, graduating in 1963. He then attended Purdue University and earned a master’s degree in physics in 1965 before getting his PhD in philosophy from Boston University in 1970. That same year, he married playwright Carolyn Boriss. After some short-lived engagements at a handful of universities, Krimsky joined the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies